Da Woon Kwack, Sung Min Park. JKAOMS 2023;49:135-41. https://doi.org/10.5125/jkaoms.2023.49.3.135

Park JW, et al. J Korean Assoc Oral Maxillofac Surg. 2017 Oct;43(5):305-311. https://doi.org/10.5125/jkaoms.2017.43.5.305

Osteoporosis is a common metabolic bone disease in patients with diabetes, which can develop simultaneously with type 2 diabetes (T2D) in postmenopausal women. Bisphosphonate (BP) is administered to patients with both conditions and may cause medication-related osteonecrosis of the jaw (MRONJ). It affects the differentiation and function of osteoclasts as well as the thickness of the cortical bone through bone mineralization. Therefore, this study aimed to investigate the effects of T2D on osteoclast differentiation and activity as well as cortical bone formation in postmenopausal patients with MRONJ. Tissue samples were collected from 10 patients diagnosed with T2D and stage III MRONJ in the experimental group and from 10 patients without T2D in the control group. A histological examination was conducted, and the expression of dendritic cell-specific transmembrane protein (DC-STAMP) and tartrate-resistant acid phosphatase (TRAP) was assessed. Cortical bone formation was analyzed using CBCT images. The number of TRAP-positive osteoclasts and DC-STAMP-positive mononuclear cells was significantly less in the experimental group (p < 0.05). Furthermore, the thickness and ratio of cortical bone were significantly greater in the experimental group (p < 0.05). In conclusion, T2D decreased the differentiation and function of osteoclasts and increased cortical bone formation in postmenopausal patients with MRONJ.

Jeon YT, et al. J Korean Assoc Oral Maxillofac Surg. 2019 Oct;45(5):294-298. https://doi.org/10.5125/jkaoms.2019.45.5.294

Joo-Ha Yoon, Sung Min Park. JKAOMS 2024;50:216-21. https://doi.org/10.5125/jkaoms.2024.50.4.216